Your browser doesn't support javascript.
loading
Cellular Mechanisms Accounting for the Refractoriness of Colorectal Carcinoma to Pharmacological Treatment.
Marin, Jose J G; Macias, Rocio I R; Monte, Maria J; Herraez, Elisa; Peleteiro-Vigil, Ana; Blas, Beatriz Sanchez de; Sanchon-Sanchez, Paula; Temprano, Alvaro G; Espinosa-Escudero, Ricardo A; Lozano, Elisa; Briz, Oscar; Romero, Marta R.
Afiliação
  • Marin JJG; Experimental Hepatology and Drug Targeting (HEVEFARM), University of Salamanca, Salamanca Biomedical Research Institute (IBSAL), 37007 Salamanca, Spain.
  • Macias RIR; Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, 28029 Madrid, Spain.
  • Monte MJ; Experimental Hepatology and Drug Targeting (HEVEFARM), University of Salamanca, Salamanca Biomedical Research Institute (IBSAL), 37007 Salamanca, Spain.
  • Herraez E; Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, 28029 Madrid, Spain.
  • Peleteiro-Vigil A; Experimental Hepatology and Drug Targeting (HEVEFARM), University of Salamanca, Salamanca Biomedical Research Institute (IBSAL), 37007 Salamanca, Spain.
  • Blas BS; Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, 28029 Madrid, Spain.
  • Sanchon-Sanchez P; Experimental Hepatology and Drug Targeting (HEVEFARM), University of Salamanca, Salamanca Biomedical Research Institute (IBSAL), 37007 Salamanca, Spain.
  • Temprano AG; Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, 28029 Madrid, Spain.
  • Espinosa-Escudero RA; Experimental Hepatology and Drug Targeting (HEVEFARM), University of Salamanca, Salamanca Biomedical Research Institute (IBSAL), 37007 Salamanca, Spain.
  • Lozano E; Experimental Hepatology and Drug Targeting (HEVEFARM), University of Salamanca, Salamanca Biomedical Research Institute (IBSAL), 37007 Salamanca, Spain.
  • Briz O; Experimental Hepatology and Drug Targeting (HEVEFARM), University of Salamanca, Salamanca Biomedical Research Institute (IBSAL), 37007 Salamanca, Spain.
  • Romero MR; Experimental Hepatology and Drug Targeting (HEVEFARM), University of Salamanca, Salamanca Biomedical Research Institute (IBSAL), 37007 Salamanca, Spain.
Cancers (Basel) ; 12(9)2020 Sep 11.
Article em En | MEDLINE | ID: mdl-32933095
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Screening_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Screening_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha